Sources of S. maltophilia¹
Stenotrophomonas maltophilia has been isolated from various sources associated with water, both inside and outside the hospital setting. Treatment strategies for S. maltophilia infections S. maltophilia is generally considered to be resistant to anti-pseudomonal beta-lactams and aminoglycosides². The preferred treatment of S. maltophilia infections has been the bacteriostatic compound trimethoprimsulfamethoxazole (TMP-SMX), but resistance to TMP-SMX is slowly emerging.
Levofloxacin may be used as an alternative antibiotic to treat infection. A recent study indicated that levofloxacin is noninferior to TMP-SMZ for the treatment of S. maltophilia infection³. Rapid development of resistance to fluoroquinolones has been observed in vitro and in vivo.
There is ongoing debate about the use of monotherapy versus combination therapy to treat S. maltophilia infections. New treatment strategies include the use of select antibiotics in synergy, e.g. TMP-SMX and tigecycline.
Other alternative treatment strategies for treating S. maltophilia infections include: · Aerosolized colistin · Aerosolized levofloxacin · Tigecycline · Moxifloxacin
Several studies are also investigating the use of antimicrobial peptides (including peptide inhibitors of beta-lactamase) and cationic compounds for the treatment of S. maltophilia infections.
